...National de la Sante et de la Recherche Medicale (INSERM) to investigate the use of nanotherapeutics...

...was chairman, president and CEO of EPS Holdings Inc. (Tokyo:4282). Contract development and manufacturing company Nanotherapeutics...

...noted that nanoparticle dynamics are a function of particle engineering as well. "As you develop nanotherapeutics...

...The partners will expand Takeda’s commercialization and technology access rights related to Nanotherapeutics’ Vero cell culture...
...rights to the technology to develop an H5N1 influenza vaccine under a December 2010 deal. Nanotherapeutics...
...disclose financial details, and Nanotherapeutics did not respond to inquiries (see BioCentury, Dec. 6, 2010). Nanotherapeutics...

...Nanotherapeutics Inc. , Alachua, Fla. Business: Drug delivery, Musculoskeletal Date announced: 2015-03-17 Note: Nanotherapeutics secured a...

...PharmAthene partnered with Nanotherapeutics to advance undisclosed biodefense products from both companies' portfolios. The partners said...
...of products to prevent and treat emerging infectious diseases and biodefense threats fits well with Nanotherapeutics'...
...in 2015. Nanotherapeutics has manufacturing capabilities in its existing facility. PharmAthene Inc. (NYSE-M:PIP), Annapolis, Md. Nanotherapeutics...

...Nanotherapeutics secured a $30 million loan facility from Hercules Technology Growth Capital. Nanotherapeutics Inc. , Alachua...

...Biomedical Advanced Research and Development Authority (BARDA) awarded contracts to Cook's Cook Pharmica subsidiary, JHP, Nanotherapeutics...
...are in development. Cook Group Inc. , Bloomington, Ind. JHP Pharmaceuticals LLC , Parsippany, N.J. Nanotherapeutics...

...Genisphere and the non-profit added the development of nanotherapeutics targeting cancer and ophthalmic diseases to an...

...antagonist Ph II H. Lundbeck A/S (CSE:LUN) Lu AE58054 Serotonin (5-HT6) receptor antagonist Ph II Nanotherapeutics...